ReviewDrug safety2014

Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.

Sascha Meyer Dos Santos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.